Lyra Therapeutics Competitors and Similar CompaniesClear all

Intersect ENT's competitors and similar companies include Codiak Biosciences and Spur Therapeutics.
Intersect ENT
Intersect ENT
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Spur Therapeutics
Spur Therapeutics
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
Founding Date
Founding Date
2003
Founding Date
2015
Founding Date
2015
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Cambridge, US HQ
Locations
Stevenage, GB HQ
Boston, US
New York, US
Employees
Employees
4337% increase
Employees
992% decrease
Employees
122

Financial

Revenue (est.)
Revenue (est.)
$106.7m (FY, 2021)
Revenue (est.)
$22.9m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$30m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$76.7m (FY, 2021)
Gross profit
N/A
Gross profit
$8.9m (FY, 2022)
Net income
Net income
($159.6m) (FY, 2021)
Net income
($37.2m) (FY, 2021)
Net income
($89m) (FY, 2022)

Operating

Products
Products
2 (FY, 2016)
Products
11 (Q2, 2020)
Products
N/A
Trademarks
Trademarks
29 (FY, 2016)
Trademarks
N/A
Trademarks
14 (May, 2024)

Funding

Total funding raised
Total funding raised
$ 102.9m
Total funding raised
$ 168.5m
Total funding raised
$ 289.3m
For sources of this data, please see the company profile

View Company Profiles

Codiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company
Spur Therapeutics
HQ
Stevenage, GB

Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.

View company